Skip to content
Echo Culture Hub

Zimbabwe Turns Down ‘One-Sided’ US Health Aid Agreement Over Data Apprehensions

Health aid image
The offered American funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has turned down a major American health deal worth $367m (£272m) over five years due to the United States' demand for sensitive data.

This move was revealed after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".

A government spokesman later clarified that the United States was demanding access to biological samples for scientific study and profit but refused to share the resulting advantages from future vaccines.

"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for continued dialogue to secure a agreement acceptable to both sides so the country's vital HIV programme can be sustained.

Broader Background

This development follows a comparable case in Kenya, where a high court suspended a related deal with the US after concerns were filed about the safety of Kenyans' health data.

After resuming office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

The agency had managed assistance for the American government, but Trump stated its spending was "wasteful" and his government was pursuing direct bilateral agreements to boost transparency and accountability.

As per statements, Sixteen nations in Africa have to date signed these new health pacts, constituting more than $18.3bn in new funding.

Details of the Rejected Deal

This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy through US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any equivalent assurance of access to any medical innovations – like new medicines or tests – that might result from that shared data," he stated.

"In essence, our country would supply the raw materials for medical research with no certainty that the end products would be accessible to our people if a future health crisis emerge."

Sovereignty and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting structures already established through the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.

"This mechanism is designed to guarantee that when a nation contributes its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to create them."

The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to further dialogue with our US partners on how future collaboration might be structured in a manner that respects the independence and interests of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but suggested that talks must proceed since a large portion of the nation's Aids initiatives were funded by external financing.

"In cases where technical issues exist, such as those relating to information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it said.

The situation emphasises the continuing debate between receiving much-needed international aid and protecting a country's data in an increasingly data-driven world.

By

Catherine Manning

A freelance arts journalist and curator based in London, specializing in contemporary music and visual arts.

Echo Culture Hub

Type to search articles.